Literature DB >> 2570933

Cytomegalovirus infection and progression to AIDS.

A Webster, J E Grundy, C A Lee, V C Emery, D G Cook, P B Kernoff, P D Griffiths.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2570933     DOI： 10.1016/s0140-6736(89)90928-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  The effect of CMV infection on progression of human immunodeficiency virus disease is a cohort of haemophilic men followed for up to 13 years from seroconversion.

Authors:  C A Sabin; A N Phillips; C A Lee; G Janossy; V Emery; P D Griffiths
Journal:  Epidemiol Infect       Date:  1995-04       Impact factor: 2.451

2.  Cytomegalovirus upregulates expression of CCR5 in central memory cord blood mononuclear cells, which may facilitate in utero HIV type 1 transmission.

Authors:  Erica L Johnson; Chanie L Howard; Joy Thurman; Kyle Pontiff; Elan S Johnson; Rana Chakraborty
Journal:  J Infect Dis       Date:  2014-07-31       Impact factor: 5.226

3.  Cytomegalovirus viremia as a risk factor for mortality prior to antiretroviral therapy among HIV-infected gold miners in South Africa.

Authors:  Katherine Fielding; Ai Koba; Alison D Grant; Salome Charalambous; John Day; Cedric Spak; Anna Wald; Meei-Li Huang; Lawrence Corey; Gavin J Churchyard
Journal:  PLoS One       Date:  2011-10-12       Impact factor: 3.240

4.  Why CMV is a candidate for elimination and then eradication.

Authors:  Paul D Griffiths; Tabitha Mahungu
Journal:  J Virus Erad       Date:  2016-07-01

Review 5.  Understanding the interaction between cytomegalovirus and tuberculosis in children: The way forward.

Authors:  Laura Olbrich; Lisa Stockdale; Robindra Basu Roy; Rinn Song; Luka Cicin-Sain; Elizabeth Whittaker; Andrew J Prendergast; Helen Fletcher; James A Seddon
Journal:  PLoS Pathog       Date:  2021-12-09       Impact factor: 6.823

Review 6.  Ongoing burden of disease and mortality from HIV/CMV coinfection in Africa in the antiretroviral therapy era.

Authors:  Emily Adland; Paul Klenerman; Philip Goulder; Philippa C Matthews
Journal:  Front Microbiol       Date:  2015-09-24       Impact factor: 5.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.